Previous close | 0.4500 |
Open | 0.4500 |
Bid | 0.0000 |
Ask | 3.1000 |
Strike | 5.00 |
Expiry date | 2024-05-17 |
Day's range | 0.4500 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 104 |
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call.
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
CAMBRIDGE, Mass., May 14, 2024--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.